Select Medical Holdings (SEM) Gross Margin (2018 - 2026)

Select Medical Holdings has disclosed Gross Margin across 9 years of filings, most recently posting 12.34% for Q1 2026.

• In Q1 2026, Gross Margin fell 100.0% year-over-year to 12.34%; the TTM figure through Mar 2026 stood at 11.31% (down 45.0% YoY), while the FY2025 annual figure was 11.54%, down 68.0% from the prior year.
• Gross Margin improved to 12.34% in Q1 2026, from 10.44% in the prior quarter.
• Over the last five years, Gross Margin for SEM reached as high as 111.41% in Q4 2022 and fell as low as 10.43% in Q3 2023.
• The 5-year median for Gross Margin is 12.04% (2022), against an average of 17.74%.
• Annual changes were most pronounced in 2022 — Gross Margin jumped 10133 bps — and 2023, when it plunged 9959 bps.
• A 5-year view of Gross Margin shows it stood at 111.41% in 2022, then plunged by 89 bps to 11.83% in 2023, then declined by 11 bps to 10.47% in 2024, then retreated by 0 bps to 10.44% in 2025, then advanced by 18 bps to 12.34% in 2026.
• According to Business Quant data, Gross Margin over the past three periods registered 12.34%, 10.44%, and 10.81% for Q1 2026, Q4 2025, and Q3 2025 respectively.